Skip to main content
Premium Trial:

Request an Annual Quote

NuSep Extends Closing Date on Share Purchase Offer

NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.

It added that to date, it has received about A$1.3 million ($1.4 million) of a targeted amount of A$2.1 million. The offering, which was announced in July and which had an original closing date of July 29, had been extended previously to Aug. 15.

The company is offering 21 million shares of iys stock at A$.10 per share, and in a prospectus said that if A$1.5 million is raised from the offering, A$200,000 would go toward the marketing of gels and IQ software, and A$1.3 million will be invested into a plasma project involving SingPharm in Singapore, which is using NuSep technology to manufacture therapeutic plasma products, and for general corporate purposes.

If A$2.1 million is raised, A$500,000 will be used for marketing of gel products and IQ software with the rest going toward the Singapore plasma project and general corporate purposes.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.